UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 599

Sortiert nach

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

British journal of cancer, 2014-02, Vol.110 (4), p.882-887

2014

Link zum Volltext

Verfügbarkeit prüfen

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Annals of oncology, 2011-12, Vol.22 (12), p.2610-2615

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

Annals of oncology, 2013-07, Vol.24 (7), p.1754-1761

2013

Link zum Volltext

Verfügbarkeit prüfen

Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)

Annals of oncology, 2021-10, Vol.32 (10), p.1267-1275

2021

Link zum Volltext

Verfügbarkeit prüfen

Medical-aid-in-dying use in the US Pacific Northwest

Annals of oncology, 2018-10, Vol.29, p.viii555-viii556

2018

Link zum Volltext

Verfügbarkeit prüfen

A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices

Annals of oncology, 2011-11, Vol.22 (11), p.2523-2529

2011

Link zum Volltext

Verfügbarkeit prüfen

Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identify a heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC)

Annals of oncology, 2019-07, Vol.30, p.iv116-iv116

2019

Link zum Volltext

Verfügbarkeit prüfen

Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii152

2018

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitors Significantly Improved Survival Outcomes in Patients with Metastatic Gastrointestinal Stromal Tumour: A Multi-Institutional Cohort Study

Current oncology (Toronto), 2020-06, Vol.27 (3), p.276-282

2020

Link zum Volltext

Verfügbarkeit prüfen

Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network Groups

Seminars in oncology, 2015-10, Vol.42 (5), p.679-680

2015

Link zum Volltext

Verfügbarkeit prüfen

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

British journal of cancer, 2013-10, Vol.109 (7), p.1744-1749

2013

Link zum Volltext

Verfügbarkeit prüfen

1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

European journal of cancer (1990), 2015-09, Vol.51, p.S241-S241

2015

Link zum Volltext

Verfügbarkeit prüfen

2007 A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405

European journal of cancer (1990), 2015-09, Vol.51, p.S329-S330

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer

Investigational new drugs, 2009-08, Vol.27 (4), p.374-378

2009

Link zum Volltext

Verfügbarkeit prüfen

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

Current oncology (Toronto), 2013-12, Vol.20 (6), p.326-332

2013

Link zum Volltext

Verfügbarkeit prüfen

Calgb/Swog 80405: Analysis of Patients Undergoing Surgery As Part of Treatment Strategy

Annals of oncology, 2014-09, Vol.25, p.v1

2014

Link zum Volltext

Verfügbarkeit prüfen

Benefits, issues, and recommendations for personalized medicine in oncology in Canada

Current oncology (Toronto), 2013-10, Vol.20 (5), p.e475-483

2013

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of GIST

The American journal of gastroenterology, 2005-10, Vol.100 (10), p.2366-2366

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma

Annals of oncology, 2001-11, Vol.12 (11), p.1575-1580

2001

Link zum Volltext

Verfügbarkeit prüfen

Nonoperative management of primary colorectal cancer in patients with stage IV disease

Annals of surgical oncology, 1999-10, Vol.6 (7), p.651-657

1999

Link zum Volltext

Verfügbarkeit prüfen

9404 ORAL Long-term Survival on S0033 – a Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumours (GISTs)

European journal of cancer (1990), 2011, Vol.47, p.S664-S664

2011

Link zum Volltext

Verfügbarkeit prüfen

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma : Results from a phase II study

Cancer, 2000-04, Vol.88 (8), p.1807-1813

2000

Link zum Volltext

Verfügbarkeit prüfen

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer

Annals of oncology, 2002, Vol.13 (1), p.87-91

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer

Journal of clinical oncology, 1997-03, Vol.15 (3), p.915-920

1997

Link zum Volltext

Verfügbarkeit prüfen

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma

The American journal of surgery, 1999-05, Vol.177 (5), p.405-410

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 599

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(544)
Mit Volltextzugriff
(545)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)

Medical-aid-in-dying use in the US Pacific Northwest

A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices

Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identify a heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC)

Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)

Tyrosine Kinase Inhibitors Significantly Improved Survival Outcomes in Patients with Metastatic Gastrointestinal Stromal Tumour: A Multi-Institutional Cohort Study

Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network Groups

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

2007 A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405

Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

Calgb/Swog 80405: Analysis of Patients Undergoing Surgery As Part of Treatment Strategy

Benefits, issues, and recommendations for personalized medicine in oncology in Canada

Epidemiology of GIST

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma

Nonoperative management of primary colorectal cancer in patients with stage IV disease

9404 ORAL Long-term Survival on S0033 – a Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumours (GISTs)

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma : Results from a phase II study

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer

Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma

Suchergebnisse filtern